Protara Therapeutics, Inc. — Director's Dealing 2020

Feb 18, 2020

SEC Form 4/A — Form 4/A

Issuer: ArTara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2020-01-09

Reporting Person: Shefferman Jesse (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-10	Stock Option (Right to Buy)	$30.00	A	111250	Acquired	2030-01-09	Common Stock (111250)	Direct

Footnotes

F1: 25% of the shares vest on the one year anniversary of January 10, 2020 and 1/48th of the shares vesting monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.